Differential Effects of HDAC8 Targeting on Foxp3+ T-Regulatory Cells and Effector T-Cells Promote Anti-Tumor Immunity

Scientists demonstrate that knocking down or inhibiting HDAC8 impaired murine Treg suppressive function in vitro and in vivo, but promoted conventional host T cell responses, thereby limiting syngeneic tumor growth.